Table 1 Basic information of controland LN patients in clinical specimens
|  | Control (N = 13) | LN (N = 19) | Overall (N = 32) |
|---|---|---|---|
Age | |||
 Mean (SD) | 55.8 (9.47) | 35.3 (11.8) | 43.6 (14.9) |
 Median [Min, Max] | 55.0 [39.0, 69.0] | 34.0 [16.0, 55.0] | 44.0 [16.0, 69.0] |
Sex | |||
 Female | 4 (30.8%) | 15 (78.9%) | 19 (59.4%) |
 Male | 9 (69.2%) | 4 (21.1%) | 13 (40.6%) |
SLE duration(years) | |||
 Mean (SD) | NA (NA) | 5.54 (5.66) | 5.54 (5.66) |
 Median [Min, Max] | NA [NA, NA] | 4.00 [0.100, 19.0] | 4.00 [0.100, 19.0] |
 Missing | 13 (100%) | 0 (0%) | 13 (40.6%) |
Cr(umol/L) | |||
 Mean (SD) | 77.3 (22.1) | 82.3 (90.4) | 80.3 (70.3) |
 Median [Min, Max] | 73.0 [49.0, 139] | 63.0 [36.0, 448] | 65.0 [36.0, 448] |
BUN(mmol/L) | |||
 Mean (SD) | 4.85 (0.802) | 7.81 (5.74) | 6.61 (4.64) |
 Median [Min, Max] | 4.40 [3.90, 6.50] | 5.70 [2.90, 23.8] | 5.40 [2.90, 23.8] |
24Â h-UTP(g) | |||
 Mean (SD) | NA (NA) | 1.86 (1.85) | 1.86 (1.85) |
 Median [Min, Max] | NA [NA, NA] | 1.40 [0.0920, 8.10] | 1.40 [0.0920, 8.10] |
 Missing | 13 (100%) | 0 (0%) | 13 (40.6%) |
SLEDAI | |||
 Mean (SD) | NA (NA) | 13.8 (4.40) | 13.8 (4.40) |
 Median [Min, Max] | NA [NA, NA] | 14.0 [6.00, 20.0] | 14.0 [6.00, 20.0] |
 Missing | 13 (100%) | 0 (0%) | 13 (40.6%) |
ds-DNA(IU/ml) | |||
 Mean (SD) | NA (NA) | 92.8 (110) | 92.8 (110) |
 Median [Min, Max] | NA [NA, NA] | 100 [0, 320] | 100 [0, 320] |
 Missing | 13 (100%) | 0 (0%) | 13 (40.6%) |
C3(g/L) | |||
 Mean (SD) | NA (NA) | 0.530 (0.337) | 0.530 (0.337) |
 Median [Min, Max] | NA [NA, NA] | 0.412 [0.170, 1.34] | 0.412 [0.170, 1.34] |
 Missing | 13 (100%) | 0 (0%) | 13 (40.6%) |
C4(g/L) | |||
 Mean (SD) | NA (NA) | 0.0955 (0.0884) | 0.0955 (0.0884) |
 Median [Min, Max] | NA [NA, NA] | 0.0750 [0.0160, 0.372] | 0.0750 [0.0160, 0.372] |
 Missing | 13 (100%) | 0 (0%) | 13 (40.6%) |